SB128
Log in to followAN ACT relating to prescription drugs.
Amend KRS 304.17A-164 to define and redefine terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans, limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution; apply provisions to health plans issued or renewed on or after January 1, 2027; EFFECTIVE January 1, 2027.
Introduced: January 27, 2026
Last action: January 27, 2026
Plain-language summary
This bill sets rules for how the cost of prescription drugs is shared between health insurance plans and their members, and requires that rebates drug manufacturers pay to insurers be passed along rather than kept by the insurer. It applies these rules to several types of health plans, including plans for state employees, college and university employees, and people enrolled in limited health benefit plans. The changes would take effect for health plans issued or renewed starting January 1, 2027. Who it may affect: Kentuckians with health insurance through their employer, state employees, and employees of public colleges and universities who use prescription drug coverage.
Legislative History
Primary Sponsor
Co-sponsors (1)
